Tanzeum is a prescription drug approved by the Food and Drug Administration (FDA) to improve glycemic control in adults with type 2 diabetes. Tanzeum is considered an adjunct treatment to diet and exercise. Tanzeum is also referred to by its drug name, Albiglutide.
Tanzeum is an incretin mimetic. Tanzeum is also a glucagon-like peptide-1 (GLP-1) receptor agonist. Tanzeum is believed to work by miming the effects of incretin, which signals the pancreas to make more insulin and prevents the liver from releasing glucose.
How do I take it?
Prescribing information states that Tanzeum should be administered once a week via subcutaneous injection.
Tanzeum comes as a single-dose pen.
The FDA-approved label for Tanzeum lists common side effects including upper respiratory infections, cold symptoms, cough, joint and back pain, injection site reactions, nausea, and diarrhea.
Rare but serious side effects listed for Tanzeum include pancreatitis, kidney problems, increased risk for thyroid cancer, and systemic allergic reactions.
For more details about this treatment, visit:
Tanzeum – GSK